Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
about
Mesenchymal stem cells as vectors for lung cancer therapySynergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinomaCarcinoma matrix controls resistance to cisplatin through talin regulation of NF-kBTargeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequencesTRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin.Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies.Corosolic acid triggers mitochondria and caspase-dependent apoptotic cell death in osteosarcoma MG-63 cells.Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL.Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells.Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effectsCisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.
P2860
Q26853498-8935989B-7F97-4A77-AD3A-CE30AE3141C7Q33811260-F1896590-D12E-4EAC-83A3-0BF80D2EE949Q33947972-A329665C-646D-4547-859A-306729ABC102Q34271222-D456A0DA-8EAC-4DD6-A697-1B03B700058FQ35647212-539C5B8A-4277-460B-B486-BCF96E0F57ABQ35880778-B1B4309D-733D-4E96-995E-8884FB7BFFA2Q37243049-DD4C21DF-9F46-440A-AA49-47EFB090A5B2Q37302038-84EC2A5E-A076-4229-A610-96AB08C9B668Q37440263-4C6E2B53-E04B-4431-8E1B-978F16C220F5Q37729428-B5F96687-8143-459E-B0EC-6813BC93917FQ39588134-DF70C353-1F0F-4A5B-830B-C184C7E11EC4Q39711397-30E8A116-A7AC-4E3E-AB2B-6A32E71569A8Q39834265-CB8EBA87-F5BC-410F-B576-70B87FE6BCACQ42575787-85172D5B-FE43-41E6-94CE-C7CB01E44951Q47100889-AF37562F-9C2F-4192-A387-31C6A407199C
P2860
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cisplatin enhances the antitum ...... ndent death signaling pathway.
@en
type
label
Cisplatin enhances the antitum ...... ndent death signaling pathway.
@en
prefLabel
Cisplatin enhances the antitum ...... ndent death signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
Cisplatin enhances the antitum ...... ndent death signaling pathway.
@en
P2093
A Loehfelm
D M Nguyen
D S Schrump
M F Ziauddin
S Shamimi-Noori
P2860
P2888
P304
P356
10.1038/SJ.CGT.7701120
P577
2008-02-29T00:00:00Z
P5875
P6179
1024076310